These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 10702940
1. [Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration]. Framme C, Toukhy HE, Sachs HG, Spiegel D, Roider J, Gabel VP, Lohmann CP. Klin Monbl Augenheilkd; 2000 Jan; 216(1):33-9. PubMed ID: 10702940 [Abstract] [Full Text] [Related]
2. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration. Krepler K, Kruger A, Tittl M, Stur M, Wedrich A. Retina; 2000 Jan; 20(3):251-6. PubMed ID: 10872929 [Abstract] [Full Text] [Related]
3. [Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration]. Hattenbach LO, Brieden M, Koch F, Gümbel H. Klin Monbl Augenheilkd; 2002 Jul; 219(7):512-8. PubMed ID: 12195317 [Abstract] [Full Text] [Related]
4. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration]. Auriol S, Mahieu L, Lequeux L, Quintyn JC, Pagot-Mathis V. J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910 [Abstract] [Full Text] [Related]
5. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas. Hesse L, Kroll P. Adv Ther; 1997 Feb; 14(5):275-80. PubMed ID: 10174620 [Abstract] [Full Text] [Related]
6. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD. Hay SR, Madonna RJ. Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129 [Abstract] [Full Text] [Related]
8. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome. Schulze SD, Hesse L. Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):717-20. PubMed ID: 12271367 [Abstract] [Full Text] [Related]
9. Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais. Ratanasukon M, Kittantong A. Eye (Lond); 2005 Dec; 19(12):1328-32. PubMed ID: 15565185 [Abstract] [Full Text] [Related]
10. [Treatment of subretinal macular hemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas]. Oficjalska-Młyńczak J, Zajac-Pytrus H, Marek J, Nizankowska MH. Klin Oczna; 2003 Dec; 105(3-4):140-6. PubMed ID: 14552171 [Abstract] [Full Text] [Related]
12. [Subretinal hematoma in age-related macular degeneration: treatment with intravitreal injection of tPA and gas]. Leguay J, Gastaud P. J Fr Ophtalmol; 2000 Oct; 23(8):797-801. PubMed ID: 11033502 [Abstract] [Full Text] [Related]
13. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972 [Abstract] [Full Text] [Related]
14. Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration. Fang IM, Lin YC, Yang CH, Yang CM, Chen MS. Eye (Lond); 2009 Feb; 23(2):397-406. PubMed ID: 17975562 [Abstract] [Full Text] [Related]
15. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study. Meyer CH, Scholl HP, Eter N, Helb HM, Holz FG. Acta Ophthalmol; 2008 Aug; 86(5):490-4. PubMed ID: 18221499 [Abstract] [Full Text] [Related]
16. [Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection, intravitreal injection of bevacizumab combined with gas tamponade: Report of 4 cases]. Abboud M, Benzerroug M, Milazzo S. J Fr Ophtalmol; 2017 Feb; 40(2):133-137. PubMed ID: 28189348 [Abstract] [Full Text] [Related]
17. Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator. Yang PM, Kuo HK, Kao ML, Chen YJ, Tsai HH. Chang Gung Med J; 2005 Dec; 28(12):852-9. PubMed ID: 16515019 [Abstract] [Full Text] [Related]
18. Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator. Singh RP, Patel C, Sears JE. Br J Ophthalmol; 2006 Apr; 90(4):429-31. PubMed ID: 16547320 [Abstract] [Full Text] [Related]
19. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement. Thompson JT, Sjaarda RN. Trans Am Ophthalmol Soc; 2005 Apr; 103():98-107; discussion 107. PubMed ID: 17057793 [Abstract] [Full Text] [Related]
20. [Combination of Intravitreal rTPA, gas and ranibizumab for extensive subfoveal haemorrhages secondary to neovascular age-related macular degeneration]. Matt G, Sacu S, Stifter E, Prünte C, Schmidt-Erfurth U. Klin Monbl Augenheilkd; 2010 Mar; 227(3):221-5. PubMed ID: 20234987 [Abstract] [Full Text] [Related] Page: [Next] [New Search]